Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities

Mercer, 2009, Long non-coding RNAs: insights into functions, Nat Rev Genet, 10, 155, 10.1038/nrg2521 Gil, 2020, Regulation of gene expression by cis-acting long non-coding RNAs, Nat Rev Genet, 21, 102, 10.1038/s41576-019-0184-5 Quinodoz, 2021, RNA promotes the formation of spatial compartments in the nucleus, Cell, 184, 5775, 10.1016/j.cell.2021.10.014 Razin, 2021, Non-coding RNAs in chromatin folding and nuclear organization, Cell Mol Life Sci, 78, 5489, 10.1007/s00018-021-03876-w Tachiwana, 2020, Gene regulation by non-coding RNAs in the 3D genome architecture, Curr Opin Genet Dev, 61, 69, 10.1016/j.gde.2020.03.002 Wang, 2021, The role of long non-coding RNAs in human imprinting disorders: prospective therapeutic targets, Front Cell Dev Biol, 9, 730014, 10.3389/fcell.2021.730014 Fatica, 2014, Long non-coding RNAs: new players in cell differentiation and development, Nat Rev Genet, 15, 7, 10.1038/nrg3606 Bhan, 2017, Long noncoding RNA and cancer: a new paradigm, Cancer Res, 77, 3965, 10.1158/0008-5472.CAN-16-2634 Batista, 2013, Long noncoding RNAs: cellular address codes in development and disease, Cell, 152, 1298, 10.1016/j.cell.2013.02.012 Penny, 1996, Requirement for Xist in X chromosome inactivation, Nature, 379, 131, 10.1038/379131a0 Okamoto, 2021, The X chromosome dosage compensation program during the development of cynomolgus monkeys, Science, 374, 10.1126/science.abd8887 Yu, 2021, B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells, Cell, 184, 1790, 10.1016/j.cell.2021.02.015 Deng, 2014, X chromosome regulation: diverse patterns in development, tissues and disease, Nat Rev Genet, 15, 367, 10.1038/nrg3687 Schulz, 2013, Role and control of X chromosome dosage in mammalian development, Curr Opin Genet Dev, 23, 109, 10.1016/j.gde.2013.01.008 Patrat, 2020, X chromosome inactivation in human development, Development, 147, dev183095, 10.1242/dev.183095 Okamoto, 2011, Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development, Nature, 472, 370, 10.1038/nature09872 Sahakyan, 2018, The role of Xist in X-chromosome dosage compensation, Trends Cell Biol, 28, 999, 10.1016/j.tcb.2018.05.005 Sidorenko, 2019, The effect of X-linked dosage compensation on complex trait variation, Nat Commun, 10, 3009, 10.1038/s41467-019-10598-y Maduro, 2016, Fitting the puzzle pieces: the bigger picture of XCI, Trends Biochem Sci, 41, 138, 10.1016/j.tibs.2015.12.003 Brown, 1992, The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus, Cell, 71, 527, 10.1016/0092-8674(92)90520-M Brown, 1991, A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome, Nature, 349, 38, 10.1038/349038a0 Brockdorff, 1991, Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome, Nature, 351, 329, 10.1038/351329a0 Markaki, 2021, Xist nucleates local protein gradients to propagate silencing across the X chromosome, Cell, 184, 6174, 10.1016/j.cell.2021.10.022 Żylicz, 2019, The implication of early chromatin changes in X chromosome inactivation, Cell, 176, 182, 10.1016/j.cell.2018.11.041 Xu, 2006, Transient homologous chromosome pairing marks the onset of X inactivation, Science, 311, 1149, 10.1126/science.1122984 Monkhorst, 2008, X inactivation counting and choice is a stochastic process: evidence for involvement of an X-linked activator, Cell, 132, 410, 10.1016/j.cell.2007.12.036 Jégu, 2017, The X chromosome in space, Nat Rev Genet, 18, 377, 10.1038/nrg.2017.17 Furlan, 2018, The ftx noncoding locus controls X chromosome inactivation independently of its RNA products, Mol Cell, 70, 462, 10.1016/j.molcel.2018.03.024 Tian, 2010, The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation, Cell, 143, 390, 10.1016/j.cell.2010.09.049 Sun, 2013, Jpx RNA activates xist by evicting CTCF, Cell, 153, 1537, 10.1016/j.cell.2013.05.028 Jonkers, 2009, RNF12 is an X-Encoded dose-dependent activator of X chromosome inactivation, Cell, 139, 999, 10.1016/j.cell.2009.10.034 Lee, 1999, Tsix, a gene antisense to Xist at the X-inactivation centre, Nat Genet, 21, 400, 10.1038/7734 Lee, 2005, Regulation of X-chromosome counting by Tsix and Xite sequences, Science, 309, 768, 10.1126/science.1113673 Bell, 1999, The protein CTCF is required for the enhancer blocking activity of vertebrate insulators, Cell, 98, 387, 10.1016/S0092-8674(00)81967-4 Navarro, 2006, Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program, Genes Dev, 20, 2787, 10.1101/gad.389006 Gontan, 2012, RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation, Nature, 485, 386, 10.1038/nature11070 Navarro, 2010, Molecular coupling of Tsix regulation and pluripotency, Nature, 468, 457, 10.1038/nature09496 Makhlouf, 2014, A prominent and conserved role for YY1 in Xist transcriptional activation, Nat Commun, 5, 4878, 10.1038/ncomms5878 Robert-Finestra, 2021, SPEN is required for Xist upregulation during initiation of X chromosome inactivation, Nat Commun, 12, 7000, 10.1038/s41467-021-27294-5 Fukuda, 2021, De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells, Stem Cell Reports, 16, 2138, 10.1016/j.stemcr.2021.07.015 Chu, 2015, Systematic discovery of Xist RNA binding proteins, Cell, 161, 404, 10.1016/j.cell.2015.03.025 Grant, 1992, Methylation of CpG sites of two X-linked genes coincides with X-inactivation in the female mouse embryo but not in the germ line, Nat Genet, 2, 161, 10.1038/ng1092-161 Jeppesen, 1993, The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression, Cell, 74, 281, 10.1016/0092-8674(93)90419-Q Chaumeil, 2002, Integrated kinetics of X chromosome inactivation in differentiating embryonic stem cells, Cytogenet Genome Res, 99, 75, 10.1159/000071577 Heard, 2001, Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation, Cell, 107, 727, 10.1016/S0092-8674(01)00598-0 Keniry, 2016, Setdb1-mediated H3K9 methylation is enriched on the inactive X and plays a role in its epigenetic silencing, Epigenetics Chromatin, 9, 16, 10.1186/s13072-016-0064-6 Pandya-Jones, 2020, A protein assembly mediates Xist localization and gene silencing, Nature, 587, 145, 10.1038/s41586-020-2703-0 Ridings-Figueroa, 2017, The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory, Genes Dev, 31, 876, 10.1101/gad.295907.117 Sunwoo, 2017, Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1), Proc Natl Acad Sci U S A, 114, 10654, 10.1073/pnas.1711206114 Yue, 2017, Xist RNA repeat E is essential for ASH2L recruitment to the inactive X and regulates histone modifications and escape gene expression, PLoS Genet, 13, 10.1371/journal.pgen.1006890 Monfort, 2015, Identification of spen as a crucial factor for xist function through forward genetic screening in haploid embryonic stem cells, Cell Rep, 12, 554, 10.1016/j.celrep.2015.06.067 Dossin, 2020, SPEN integrates transcriptional and epigenetic control of X-inactivation, Nature, 578, 455, 10.1038/s41586-020-1974-9 McHugh, 2015, The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3, Nature, 521, 232, 10.1038/nature14443 Schoeftner, 2006, Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing, EMBO J, 25, 3110, 10.1038/sj.emboj.7601187 Almeida, 2017, PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation, Science, 356, 1081, 10.1126/science.aal2512 Bousard, 2019, The role of Xist-mediated Polycomb recruitment in the initiation of X-chromosome inactivation, EMBO Rep, 20, 10.15252/embr.201948019 Pintacuda, 2017, hnRNPK recruits PCGF3/5-PRC1 to the Xist RNA B-repeat to establish polycomb-mediated chromosomal silencing, Mol Cell, 68, 955, 10.1016/j.molcel.2017.11.013 Lee, 2013, X-inactivation, imprinting, and long noncoding RNAs in health and disease, Cell, 152, 1308, 10.1016/j.cell.2013.02.016 Dixon-McDougall, 2021, Independent domains for recruitment of PRC1 and PRC2 by human XIST, PLoS Genet, 17, 10.1371/journal.pgen.1009123 Patil, 2016, m(6)A RNA methylation promotes XIST-mediated transcriptional repression, Nature, 537, 369, 10.1038/nature19342 Coker, 2020, The role of the Xist 5' m6A region and RBM15 in X chromosome inactivation, Wellcome Open Res, 5, 31, 10.12688/wellcomeopenres.15711.1 Engreitz, 2013, The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome, Science, 341, 1237973, 10.1126/science.1237973 Jeon, 2011, YY1 tethers Xist RNA to the inactive X nucleation center, Cell, 146, 119, 10.1016/j.cell.2011.06.026 Chen, 2016, Xist recruits the X chromosome to the nuclear Lamina to enable chromosome-wide silencing, Science, 354, 468, 10.1126/science.aae0047 Colognori, 2019, Xist deletional analysis reveals an interdependency between xist RNA and polycomb complexes for spreading along the inactive X, Mol Cell, 74, 101, 10.1016/j.molcel.2019.01.015 Wutz, 2000, A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation, Mol Cell, 5, 695, 10.1016/S1097-2765(00)80248-8 Chan, 2011, Diverse factors are involved in maintaining X chromosome inactivation, Proc Natl Acad Sci U S A, 108, 16699, 10.1073/pnas.1107616108 Schultz, 2002, SETDB1:a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins, Genes Dev, 16, 919, 10.1101/gad.973302 Lopes-Ramos, 2020, Genome-wide sex and gender differences in cancer, Front Oncol, 10, 597788, 10.3389/fonc.2020.597788 Siegel, 2021, Cancer statistics, 2021, CA Cancer J Clin, 71, 7, 10.3322/caac.21654 Libert, 2010, The X chromosome in immune functions: when a chromosome makes the difference, Nat Rev Immunol, 10, 594, 10.1038/nri2815 Park, 2020, Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: a systematic review and meta-analysis, EClinicalMedicine, 26, 100519, 10.1016/j.eclinm.2020.100519 Brodin, 2021, Immune determinants of COVID-19 disease presentation and severity, Nat Med, 27, 28, 10.1038/s41591-020-01202-8 Wenham, 2020, Gender and COVID-19 Working Group. COVID-19:the gendered impacts of the outbreak, Lancet, 395, 846, 10.1016/S0140-6736(20)30526-2 Li, 2020, Sex differences in oncogenic mutational processes, Nat Commun, 11, 4330, 10.1038/s41467-020-17359-2 Zhu, 2019, Sex disparities in cancer, Cancer Lett, 466, 35, 10.1016/j.canlet.2019.08.017 Galasso, 2020, Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries, Proc Natl Acad Sci U S A, 117, 27285, 10.1073/pnas.2012520117 Vlassoff, 2007, Gender differences in determinants and consequences of health and illness, J Health Popul Nutr, 25, 47 Klein, 2016, Sex differences in immune responses, Nat Rev Immunol, 16, 626, 10.1038/nri.2016.90 Youness, 2021, Escape from X chromosome inactivation and the female predominance in autoimmune diseases, Int J Mol Sci, 22, 1114, 10.3390/ijms22031114 Fish, 2008, The X-files in immunity: sex-based differences predispose immune responses, Nat Rev Immunol, 8, 737, 10.1038/nri2394 Pinheiro, 2011, X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females, Bioessays, 33, 791, 10.1002/bies.201100047 Berletch, 2015, Escape from X inactivation varies in mouse tissues, PLoS Genet, 11, e1005079, 10.1371/journal.pgen.1005079 Carrel, 2005, X-inactivation profile reveals extensive variability in X-linked gene expression in females, Nature, 434, 400, 10.1038/nature03479 Tukiainen, 2017, Landscape of X chromosome inactivation across human tissues, Nature, 550, 244, 10.1038/nature24265 Balaton, 2015, Derivation of consensus inactivation status for X-linked genes from genome-wide studies, Biol Sex Differ, 6, 35, 10.1186/s13293-015-0053-7 Pyfrom, 2021, The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients, Proc Natl Acad Sci U S A, 118, 10.1073/pnas.2024624118 Syrett, 2019, Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases, JCI Insight, 4, 10.1172/jci.insight.126751 Syrett, 2018, Diversity of epigenetic features of the inactive X-chromosome in NK cells, dendritic cells, and macrophages, Front Immunol, 9, 3087, 10.3389/fimmu.2018.03087 Wang, 2016, Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X, Proc Natl Acad Sci U S A, 113, E2029, 10.1073/pnas.1520113113 Syrett, 2017, Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells, PLoS Genet, 13, 10.1371/journal.pgen.1007050 Cancro, 2020, Age-associated B cells, Annu Rev Immunol, 38, 315, 10.1146/annurev-immunol-092419-031130 Karnell, 2017, Role of CD11c + T-bet + B cells in human health and disease, Cell Immunol, 321, 40, 10.1016/j.cellimm.2017.05.008 Celhar, 2012, TLR7 and TLR9 in SLE: when sensing self Goes wrong, Immunol Res, 53, 58, 10.1007/s12026-012-8270-1 Woodruff, 2020, Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19, Nat Immunol, 21, 1506, 10.1038/s41590-020-00814-z Dunford, 2017, Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias, Nat Genet, 49, 10, 10.1038/ng.3726 Pinto, 2015, Genomic landscape of paediatric adrenocortical tumours, Nat Commun, 6, 6302, 10.1038/ncomms7302 Jiang, 2015, Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma, Nat Genet, 47, 1061, 10.1038/ng.3358 Dalgliesh, 2010, Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes, Nature, 463, 360, 10.1038/nature08672 Ntziachristos, 2014, Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia, Nature, 514, 513, 10.1038/nature13605 Shi, 2021, UTX condensation underlies its tumour-suppressive activity, Nature, 597, 726, 10.1038/s41586-021-03903-7 van Haaften, 2009, Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer, Nat Genet, 41, 521, 10.1038/ng.349 Van der Meulen, 2015, The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia, Blood, 125, 13, 10.1182/blood-2014-05-577270 Kaneko, 2018, X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism, Sci Adv, 4, eaar5598, 10.1126/sciadv.aar5598 Hu, 2017, Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer, Oncotarget, 8, 94554, 10.18632/oncotarget.21791 Fang, 2016, Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression, Biochem Biophys Res Commun, 478, 811, 10.1016/j.bbrc.2016.08.030 Liu, 2019, Upregulation of long noncoding RNA XIST is associated with poor prognosis in human cancers, J Cell Physiol, 234, 6594, 10.1002/jcp.27400 Liu, 2019, LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2, J Cell Physiol, 234, 13747, 10.1002/jcp.28054 Sun, 2018, Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway, Gene, 665, 141, 10.1016/j.gene.2018.04.014 Song, 2017, Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p, J BUON, 22, 696 Sun, 2017, Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy, Oncol Rep, 38, 3347 Wang, 2017, The long non-coding RNA XIST controls non-small cell lung cancer proliferation and invasion by modulating miR-186-5p, Cell Physiol Biochem, 41, 2221, 10.1159/000475637 Zhang, 2017, The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer, Acta Pharmacol Sin, 38, 371, 10.1038/aps.2016.133 Zhou, 2019, XIST promote the proliferation and migration of non-small cell lung cancer cells via sponging miR-16 and regulating CDK8 expression, Am J Transl Res, 11, 6196 Zhang, 2019, Long non-coding RNA (lncRNA) X-inactive specific transcript (XIST) plays a critical role in predicting clinical prognosis and progression of colorectal cancer, Med Sci Monit, 25, 6429, 10.12659/MSM.915329 Hu, 2019, Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1, J Cell Biochem, 120, 6330, 10.1002/jcb.27920 Liu, 2018, Long noncoding RNA XIST regulates miR-137-EZH2 axis to promote tumor metastasis in colorectal cancer, Oncol Res, 27, 99, 10.3727/096504018X15195193936573 Xu, 2018, LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells, Cancer Cell Int, 18, 41, 10.1186/s12935-018-0540-0 Zhou, 2019, Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer, Exp Ther Med, 18, 3475 Li, 2018, Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer, Cancer Lett, 418, 185, 10.1016/j.canlet.2018.01.036 Qiu, 2019, Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells, Eur Rev Med Pharmacol Sci, 23, 8391 Jiang, 2020, Knockdown of lncRNA XIST suppresses cell tumorigenicity in human non-small cell lung cancer by regulating miR-142-5p/PAX6 axis, Onco Targets Ther, 13, 4919, 10.2147/OTT.S238808 Rong, 2020, Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p, Thorac Cancer, 11, 659, 10.1111/1759-7714.13310 Wang, 2018, Knockdown of LncRNA-XIST suppresses proliferation and TGF-β1-induced EMT in NSCLC through the Notch-1 pathway by regulation of miR-137, Genet Test Mol Biomarkers, 22, 333, 10.1089/gtmb.2018.0026 Xiong, 2017, The long non-coding RNA XIST interacted with miR-124 to modulate bladder cancer growth, invasion and migration by targeting androgen receptor (AR), Cell Physiol Biochem, 43, 405, 10.1159/000480419 Lombard, 2015, The emerging role of the androgen receptor in bladder cancer, Endocr Relat Cancer, 22, 10.1530/ERC-15-0209 Laor, 1985, Androgen receptors in bladder tumors, Urology, 25, 161, 10.1016/0090-4295(85)90534-5 Miyamoto, 2007, Promotion of bladder cancer development and progression by androgen receptor signals, J Natl Cancer Inst, 99, 558, 10.1093/jnci/djk113 Garg, 2019, WNT/β-catenin signaling in urothelial carcinoma of bladder, World J Nephrol, 8, 83, 10.5527/wjn.v8.i5.83 Overdevest, 2012, CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated, Proc Natl Acad Sci U S A, 109, 10.1073/pnas.1113960109 Groenendijk, 2016, ERBB2 mutations characterize a subgroup of muscle-invasive bladder cancers with excellent response to neoadjuvant chemotherapy, Eur Urol, 69, 384, 10.1016/j.eururo.2015.01.014 Inoue, 2018, ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor, Am J Cancer Res, 8, 2325 Zhao, 2014, Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment, Eur J Endocrinol, 171, 527, 10.1530/EJE-14-0278 Chen, 2017, Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer, Cell Death Dis, 8, 10.1038/cddis.2017.421 Zhang, 2019, Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells, J Cell Mol Med, 23, 3151, 10.1111/jcmm.14148 Yang, 2020, LncRNA XIST modulates HIF-1A/AXL signaling pathway by inhibiting miR-93-5p in colorectal cancer, Mol Genet Genomic Med, 8, e1112, 10.1002/mgg3.1112 Li, 2021, Long noncoding RNA XIST knockdown suppresses the growth of colorectal cancer cells via regulating microRNA-338-3p/PAX5 axis, Eur J Cancer Prev, 30, 132, 10.1097/CEJ.0000000000000596 Zeng, 2021, The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer, Cancer Med, 10, 2423, 10.1002/cam4.3777 Yip, 2008, Bcl-2 family proteins and cancer, Oncogene, 27, 6398, 10.1038/onc.2008.307 Firestein, 2008, CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity, Nature, 455, 547, 10.1038/nature07179 Marei, 2021, p53 signaling in cancer progression and therapy, Cancer Cell Int, 21, 703, 10.1186/s12935-021-02396-8 Yang, 2020, METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST, Mol Cancer, 19, 46, 10.1186/s12943-020-1146-4 Sung, 2021, Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Zheng, 2018, Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155/CDX1 axis, Biochem Biophys Res Commun, 498, 1002, 10.1016/j.bbrc.2018.03.104 Huang, 2016, Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression, Oncotarget, 7, 43256, 10.18632/oncotarget.9673 Liu, 2021, Long noncoding RNA XIST acts as a ceRNA of miR-362-5p to suppress breast cancer progression, Cancer Biother Radiopharm, 36, 456 Xing, 2018, Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis, Cancer Res, 78, 4316, 10.1158/0008-5472.CAN-18-1102 Kim, 2014, UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells, Cancer Res, 74, 1705, 10.1158/0008-5472.CAN-13-1896 Xu, 2018, Long noncoding RNA XIST promotes proliferation and invasion by targeting miR-141 in papillary thyroid carcinoma, Onco Targets Ther, 11, 5035, 10.2147/OTT.S170439 Liu, 2018, LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling, J Exp Clin Cancer Res, 37, 279, 10.1186/s13046-018-0950-9 Du, 2021, LncRNA XIST promotes migration and invasion of papillary thyroid cancer cell by modulating miR-101-3p/CLDN1 axis, Biochem Genet, 59, 437, 10.1007/s10528-020-09985-8 Hu, 2020, Long non-coding RNA XIST is down-regulated and correlated to better prognosis in ovarian cancer, Math Biosci Eng, 17, 2070, 10.3934/mbe.2020110 Huang, 2020, XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way, Cancer Cell Int, 20, 436, 10.1186/s12935-020-01500-8 Wang, 2018, Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p, J Gynecol Oncol, 29, e99, 10.3802/jgo.2018.29.e99 Guo, 2021, Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a, Hum Cell, 34, 579, 10.1007/s13577-020-00469-w Huang, 2002, Relationship of XIST expression and responses of ovarian cancer to chemotherapy, Mol Cancer Ther, 1, 769 Meng, 2021, Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335/BCL2L2 axis, World J Surg Oncol, 19, 165, 10.1186/s12957-021-02274-7 Jiang, 2021, Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression, Cell Death Dis, 12, 145, 10.1038/s41419-020-03358-0 Zhu, 2018, LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a, Biomed Pharmacother, 105, 789, 10.1016/j.biopha.2018.05.053 Chen, 2019, Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1, Cancer Cell Int, 19, 45, 10.1186/s12935-019-0744-y Liu, 2020, Long noncoding RNA XIST contributes to cervical cancer development through targeting miR-889-3p/SIX1 axis, Cancer Biother Radiopharm, 35, 640 Gong, 2008, Analysis of X chromosome inactivation in autism spectrum disorders, Am J Med Genet B Neuropsychiatr Genet, 147B, 830, 10.1002/ajmg.b.30688 Guo, 2022, Sex differences in Alzheimer's disease: insights from the multiomics landscape, Biol Psychiatr, 91, 61, 10.1016/j.biopsych.2021.02.968 Brand, 2021, The impact of X-chromosome inactivation on phenotypic expression of X-linked neurodevelopmental disorders, Brain Sci, 11, 904, 10.3390/brainsci11070904 Plenge, 1997, A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation, Nat Genet, 17, 353, 10.1038/ng1197-353 Talebizadeh, 2005, Brief report: non-random X chromosome inactivation in females with autism, J Autism Dev Disord, 35, 675, 10.1007/s10803-005-0011-z Sripathy, 2017, Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression, Proc Natl Acad Sci U S A, 114, 1619, 10.1073/pnas.1621356114 Good, 2021, MeCP2:the genetic driver of rett syndrome epigenetics, Front Genet, 12, 620859, 10.3389/fgene.2021.620859 Amir, 1999, Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2, Nat Genet, 23, 185, 10.1038/13810 Xiol, 2019, X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients, Sci Rep, 9, 11983, 10.1038/s41598-019-48385-w Wang, 2016, Regulation of LRRK2 promoter activity and gene expression by Sp1, Mol Brain, 9, 33, 10.1186/s13041-016-0215-5 Lee, 2012, Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease, Trends Pharmacol Sci, 33, 365, 10.1016/j.tips.2012.04.001 Cao, 2018, Leucine-rich repeat kinase 2 aggravates secondary brain injury induced by intracerebral hemorrhage in rats by regulating the P38 MAPK/Drosha pathway, Neurobiol Dis, 119, 53, 10.1016/j.nbd.2018.07.024 Di Maio, 2018, LRRK2 activation in idiopathic Parkinson's disease, Sci Transl Med, 10, eaar5429, 10.1126/scitranslmed.aar5429 Zhou, 2021, LncRNA XIST sponges miR-199a-3p to modulate the Sp1/LRRK2 signal pathway to accelerate Parkinson's disease progression, Aging (Albany NY), 13, 4115, 10.18632/aging.202378 Du, 2020, Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124, Cell Biol Int, 44, 630, 10.1002/cbin.11263 Yan, 2022, lncRNA XIST induces Aβ accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer's disease, J Neurogenet, 36, 11, 10.1080/01677063.2022.2028784 Qin, 2020, Sex differences in the proliferation of pulmonary artery endothelial cells: implications for plexiform arteriopathy, J Cell Sci, 133, jcs237776, 10.1242/jcs.237776 Batton, 2018, Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease, Biol Sex Differ, 9, 15, 10.1186/s13293-018-0176-8 Qin, 2021, Up-regulation of the long noncoding RNA X-inactive-specific transcript and the sex bias in pulmonary arterial hypertension, Am J Pathol, 191, 1135, 10.1016/j.ajpath.2021.03.009 Patel, 2013, A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension, J Biol Chem, 288, 25701, 10.1074/jbc.M113.502674 Atkins, 2007, Role of Krüppel-like transcription factors in endothelial biology, Circ Res, 100, 1686, 10.1161/01.RES.0000267856.00713.0a Shapiro, 2012, Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management, Chest, 141, 363, 10.1378/chest.10-3114 Mair, 2014, Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response, Br J Pharmacol, 171, 567, 10.1111/bph.12281 Xu, 2010, Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats, Respir Res, 11, 182, 10.1186/1465-9921-11-182 Yuan, 2013, Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways, Eur Respir J, 41, 1116, 10.1183/09031936.00044112 Ye, 2011, Atractylenolide II induces G1 cell-cycle arrest and apoptosis in B16 melanoma cells, J Ethnopharmacol, 136, 279, 10.1016/j.jep.2011.04.020 Huang, 2019, Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells, Food Chem Toxicol, 131, 110537, 10.1016/j.fct.2019.05.045 Peng, 2019, miR-34a enhances the susceptibility of gastric cancer to platycodin D by targeting survivin, Pathobiology, 86, 296, 10.1159/000502913 Lu, 2015, Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D, Chin J Nat Med, 13, 673 Chen, 2020, Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo, Exp Cell Res, 396, 112281, 10.1016/j.yexcr.2020.112281 Chen, 2021, Long non-coding RNAs: from disease code to drug role, Acta Pharm Sin B, 11, 340, 10.1016/j.apsb.2020.10.001 Setten, 2019, The Current state and future directions of RNAi-based therapeutics, Nat Rev Drug Discov, 18, 421, 10.1038/s41573-019-0017-4 Rinaldi, 2018, Antisense oligonucleotides: the next frontier for treatment of neurological disorders, Nat Rev Neurol, 14, 9, 10.1038/nrneurol.2017.148 Gardiner, 2010, Molecular basis of pharmacotherapies for cognition in Down syndrome, Trends Pharmacol Sci, 31, 66, 10.1016/j.tips.2009.10.010 Jiang, 2013, Translating dosage compensation to trisomy 21, Nature, 500, 296, 10.1038/nature12394 Chiang, 2018, Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro, Nat Commun, 9, 5180, 10.1038/s41467-018-07630-y Spiering, 2021, Why females do better: the X chromosomal TLR7 gene-dose effect in COVID-19, Front Immunol, 12, 756262, 10.3389/fimmu.2021.756262 Kopp, 2018, Functional classification and experimental dissection of long noncoding RNAs, Cell, 172, 393, 10.1016/j.cell.2018.01.011